Claim OwnershipThe RetinaCare Podcast
Subscribed: 1Played: 3
Subscribe
© Copyright 2024 All rights reserved.
Description
This podcast brings you information based on clinical published peer-reviewed research focused on your eye health and vision science. If you care about your vision and your eyes, you’ll care about this! Brought to you by RetinaCare, (www.RetinaCareOregon.com) and Dr. Peter Karth, MD, MBA, FASRS FACS.
*Not Medical Advice. Please talk to your doctor. We try to be as correct as possible, but there may be errors of fact or implication. Do your own research before making decisions, please.*
*Not Medical Advice. Please talk to your doctor. We try to be as correct as possible, but there may be errors of fact or implication. Do your own research before making decisions, please.*
1 Episodes
Reverse
New research suggests a link between semaglutide, a popular weight-loss drug, and an increased risk of NAION. A study in JAMA Ophthalmology found that individuals taking semaglutide had a higher risk of developing NAION compared to those taking other medications. The risk was particularly pronounced within the first year of semaglutide use. While the study doesn't prove causation, the findings raise concerns about potential side effects of this drug. *Not Medical Advice*
Comments
Download from Google Play
Download from App Store
United States